1. Belousov Yu.B. Generiki - mify i realii. Remedium 2003; iyul'-avgust: 4-9.
2. Belousov Yu.B., Zyryanov S.K. Generiki i brendy: pro et contra. Kachestvennaya klinicheskaya praktika 2003; M; 2: 1-5.
3. Boldyreva S.R., Sravnitel'naya otsenka sovremennykh antiepilepticheskikh preparatov pri visochnoi medial'noi epilepsii u detei, Klinicheskaya epileptologiya 2007 №1, 23- 27
4. Voronina T.A. Farmakologiya sovremennykh protivosudorozhnykh sredstv. Antikonvul'santy v psikhiatricheskoi i nevrologicheskoi praktike. Meditsinskoe informatsionnoe agentstvo 1994. S-Pb: 3-30.
5. S. A. Gromov S. D. Tabulina Ispol'zovanie val'proatovenerikov (enkorat-khrono) v lechenii bol'nykh epilepsiei, Zhurnal nevrologii i psikhiatrii, 2005 №4 34-37
6. Drobizhev M.Yu. Brendy i generiki: argumenty i fakty. Zhurn. psikhiatrii i psikhofarmakologii 2007; 3: 43-49
7. Dubenko A.E., Litovchenko T.A. Effektivnost' val'proevoi kisloty, lamotridzhina i topiramata dlya lecheniya generalizovannykh i neklassifitsiruemykh epilepticheskikh pripadkov po dannym issledovaniya SANAD Vіsnik epіleptologії 2007; 2: 13-23.
8. Karlov V.A., Vlasov P.N., Khabibova A.O. Depakin 300 i vepakin-khrono v terapii epilepsii. Zhurn nevrol i psikhiat 1999; 99: 10: 20-26.
9. Kataeva M.F., Kolesnik E.A. Sluchai perevoda patsienta s original'nogo preparata na generik, Zhurn. Klinicheskaya epileptologiya 2007;1, 15-16
10. Kuz'minova M.V., Berezina I.Yu. Effektivnost' Depakina V monoterapii pri lechenii epilepsii, Klinicheskaya epileptologiya 2007 №1 16-19
11. Meshkovskii A.P. Mesto generikov v lekarstvennom obespechenii. Farmateka 2003; 3:103-104.
12. Piliya S.V. i soavt. Opyt primeneniya preparatov val'proevoi kisloty. Detskaya bol'nitsy 2006;2, 16-21
13. Rudakova I.V., Kotov S.V., Belova A.Ya., Kotov A.S., Morozova O.S., Idiopaticheskaya generalizovannaya epilepsiya. Opyt raboty vzroslogo epileptologa, Zhurnal nevrologii i psikhiatrii, 2007 №2 39-43
14. Sokolov A.V.., Belousov Yu.B., Tishchenkova I.F., Sravnitel'naya farmakokinetika preparatov val'proevoi kisloty s kontroliruemym vysvobozhdeniem, Remedium; elektronnaya versiya ot 27. 11.2007, http://www.remedium.ru
15. Kharchuk S.M.,. Gekht A.B, E.D. Belousova A.B, i dr. Ratsional'naya farmakoterapiya epilepsii: traditsionnye i novye podkhody k preodoleniyu starykh problem , Remedium 2007; 11; 1: 16-17.
16. Shershever A.S., Sokolova E. V., Sulimov A.V. Sryv remissii u bol'nykh epilepsiei pri smene original'nykh antiepilepticheskikh preparatov na generiki. Klinicheskaya epileptologiya 2007; 1, 10-12
17. Yarema L.N. , Izmenenie kachestva zhizni i techeniya zabolevaniya u patsientov s epilepsiei pri zamene original'nykh protivoepilepticheskikh preparatov generikami Klinicheskaya epileptologiya 2007;1, 13-14
18. Jedrzejzak J., Kunchikova M. and Margureanu S., An observational study of first-line valproate monotherapy in focal epilepsy., European Journal of Neurology, 2008, 15, 66-72.
19. Meyer G.F. History and regulatory issues of generic drugs. Transplantation Proceedings 1999; 31 (Suppl. 3A):10S-12S.
20. Majkowski J., Lasson W., Daniel W., et al, Brand-name and generic drugs in the treatment of epilepsy - biopharmaceutical, pharmacological, clinical and economic. Epileptologia 2004;12;4 , 7-12
21. Nikolson A., Appleton R.E., Chandwick D. W., Smith D. F., The relationship between with valproate, lamotrigine, and topiramate and the prognosis of the idiopathic generalised epilepsies., J. Neurol. Neurosurg. Psychiatry, 2004, V.75, p. 75-79